Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus vs Rapamycin in Older Kidney Transplant Recipients
NCT00290069Phase 4Unknown
- Sponsor
- Sociedad Andaluza de Trasplantes de Órganos y Tejidos
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus, sirolimus in graft rejection, sponsored by Sociedad Andaluza de Trasplantes de Órganos y Tejidos. Status: unknown.
02
Drugs
tacrolimussirolimus
03
Conditions
graft rejection
Beyond the preview
Go deeper on NCT00290069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00290069.